WHO Prequalifies India's First Indigenous HPV Vaccine Cervavac

The World Health Organization has granted prequalification to Cervavac, India's first indigenous HPV vaccine developed by the Serum Institute of India. The gender-neutral vaccine targets HPV types 6, 11, 16, and 18, and is approved for people aged nine to 26. The WHO nod makes it eligible for procurement by UN agencies, potentially expanding global access.